GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by GAMMA Investing LLC

GAMMA Investing LLC lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 8,016 shares of the company’s stock after acquiring an additional 355 shares during the period. GAMMA Investing LLC’s holdings in GE HealthCare Technologies were worth $627,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in the company. Mesirow Financial Investment Management Inc. boosted its holdings in GE HealthCare Technologies by 39.6% in the third quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company’s stock worth $383,000 after purchasing an additional 1,159 shares during the period. LMR Partners LLP acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at about $7,387,000. Principal Financial Group Inc. boosted its holdings in shares of GE HealthCare Technologies by 1.9% in the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock valued at $94,780,000 after buying an additional 19,010 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in shares of GE HealthCare Technologies during the 3rd quarter valued at about $1,396,000. Finally, Bank of Montreal Can raised its stake in GE HealthCare Technologies by 27.5% during the second quarter. Bank of Montreal Can now owns 696,446 shares of the company’s stock worth $54,964,000 after acquiring an additional 150,137 shares during the period. 82.06% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.27% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on GEHC shares. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their target price for the company from $84.00 to $74.00 in a report on Thursday, September 26th. Evercore ISI upped their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. Stifel Nicolaus raised their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research report on Wednesday, September 18th. Finally, JPMorgan Chase & Co. assumed coverage on shares of GE HealthCare Technologies in a research report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective on the stock. One analyst has rated the stock with a sell rating, four have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average target price of $95.46.

GE HealthCare Technologies Stock Up 2.7 %

GEHC opened at $80.52 on Friday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The company has a market capitalization of $36.79 billion, a PE ratio of 22.12, a P/E/G ratio of 2.90 and a beta of 1.07. The stock’s fifty day moving average is $82.45 and its 200-day moving average is $83.94. GE HealthCare Technologies Inc. has a one year low of $71.31 and a one year high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The firm had revenue of $4.86 billion for the quarter, compared to analysts’ expectations of $4.87 billion. During the same period in the previous year, the business earned $0.99 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up .9% compared to the same quarter last year. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.30%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.